At the European Society for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Thomas Danne discusses his session on the latest clinical evidence supporting the use of sotagliflozin in type 1 diabetes.
1. What is the rationale for the use of sotagliflozin in as an adjunct to insulin therapy in type 1 diabetes (T1D)? (0:05)
2. What clinical evidence supports the use of sotagliflozin in T1D? (1:00)
3. What is the effect of sotagliflozin on the risk of diabetic ketoacidosis and urinary tract infections? (1:57)
4. Which patients are most likely to benefit from this treatment? (2:58)
5. What further research is needed before this treatment enters routine clinical use?
Thomas Danne has no conflicts of interest to declare in relation to this video.
Filmed at the Annual Meeting of the European Association of the Study of Diabetes (EASD) Barcelona, Spain 2019.
Share this Video
Related Videos In Diabetes
Sanjay Kalra: Research Highlights from 2021
We were delighted to speak with our editorial board member Dr Sanjay Kalra (Bharti Hospital, Karnal, India) around last year’s research highlights in the field of diabetes and obesity. Questions In the field of diabetes and obesity, what have been the most exciting research highlights of 2021? (0:32) What is your advice for health care […]
Gian Paolo Fadini, EASD 2021: Real-world Data from the RESTORE-2 Study
touchENDOCRINOLOGY caught up with Prof Gian Paolo Fadini (University Hospital of Padova, Italy) virtually during the EASD Annual Meeting 2021 conference to discuss the real-world data from the RESTORE-2 study. Questions 1. What have randomized controlled trials taught us about the efficacy and safety of second-generation basal insulins? (00:18-01:31) 2. What were the aims, design […]
Anna-Maria Lampousi, EASD 2021: Dietary Factors and Risk of Islet Autoimmunity and Type 1 Diabetes
touchENDOCRINOLOGY caught up with Anna-Maria Lampousi (Karolinska Institutet, Stockholm, Sweden) virtually during the EASD Annual Meeting 2021 conference to discuss her systematic review and meta-analysis on dietary factors and risk of islet autoimmunity and type 1 diabetes. Questions 1. What is known about the associations between dietary components and type 1 diabetes, and what gaps […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!